Knockdown of nuclear protein 1 delays pathological pro-gression of osteoarthritis through inhibiting chondrocyte ferroptosis

Taiyang Liao, Zhenyuan Ma, Deren Liu, Lei Shi, Jun Mao, Peimin Wang, Liang DingJournal of Zhejiang University (Medical Sciences) 2024 · DOI

Abstract

Osteoarthritis (OA) is characterized by the progressive degradation of articular cartilage. Recent evidence suggests that ferroptosis—an iron-dependent form of regulated cell death—plays a pivotal role in this process. This study demonstrates that knocking down Nuclear Protein 1 (Nupr1) inhibits ferroptosis in mouse chondrocytes, thereby delaying the pathological progression of OA in both cellular and animal models.

Introduction

Osteoarthritis remains a leading cause of global disability, yet current clinical interventions primarily focus on symptom management rather than disease modification. Ferroptosis, driven by the accumulation of iron and subsequent lipid peroxidation (the "rusting" of cell membranes), has emerged as a critical driver of cartilage loss. This research investigates whether Nupr1, a protein involved in cellular stress responses, acts as a regulatory switch for ferroptosis in chondrocytes.

Methodology

The study utilized a comprehensive experimental framework:

  • In Vitro Model: Primary mouse chondrocytes were isolated and treated with IL-1β to simulate the inflammatory environment of an osteoarthritic joint. Small interfering RNA (siRNA) was employed to silence Nupr1 expression.
  • In Vivo Model: OA was induced in 7-week-old C57BL/6J mice via Destabilization of Medial Meniscus (DMM) surgery. Nupr1 was targeted using an Adeno-associated virus (AAV5) to deliver short hairpin RNA (shRNA) directly into the joint.
  • Detection Assays: The team used FerroOrange staining to monitor labile iron levels, C11-BODIPY for lipid peroxidation, and biochemical assays to measure malondialdehyde (MDA) and glutathione (GSH) levels.

Results and Discussion

Nupr1 as a Ferroptosis Regulator

The researchers identified that Nupr1 knockdown modulates the P53/SLC7A11/GPX4 axis. Silencing Nupr1 led to the downregulation of pro-ferroptotic factors like P53 and ACSL4, while simultaneously upregulating SLC7A11 and GPX4, the cell's primary antioxidant defenses against ferroptosis.

Fluorescence imaging of chondrocytes (FerroOrange staining) demonstrating that Nupr1 knockdown (siNupr1) significantly reduces the accumulation of labile iron induced by inflammatory stress (IL-1β).

Therapeutic Impact in OA Models

In cellular assays, knocking down Nupr1 successfully "rescued" chondrocytes from IL-1β-induced death, evidenced by a significant decrease in MDA and a restoration of GSH levels ($P < 0.01$). In the animal model, AAV-mediated silencing of Nupr1 significantly improved OARSI scores, indicating better preservation of joint structure and reduced cartilage erosion compared to untreated OA groups ($P < 0.01$).

Conclusion

This study identifies Nupr1 as a critical driver of ferroptosis in osteoarthritis. By inhibiting the P53/SLC7A11/GPX4 axis, Nupr1 knockdown offers a protective effect against cartilage degradation. While clinical translation requires further investigation into species-specific differences and long-term safety, Nupr1 represents a promising therapeutic target for disease-modifying OA treatments.

Summary updated

Abstract

Knockdown of <i>Nupr1</i> can delay the pathological progression of osteoarthritis through inhibiting ferroptosis in mouse chondrocytes.
BibTeX
@article{liao2024knockdown,
  author = {Taiyang Liao and Zhenyuan Ma and Deren Liu and Lei Shi and Jun Mao and Peimin Wang and Liang Ding},
  title = {{Knockdown of nuclear protein 1 delays pathological pro-gression of osteoarthritis through inhibiting chondrocyte ferroptosis}},
  journal = {Journal of Zhejiang University (Medical Sciences)},
  year = {2024},
  doi = {10.3724/zdxbyxb-2024-0091},
}
Figure